TIDMHAYD
RNS Number : 2643E
Haydale Graphene Industries PLC
27 February 2020
The information contained within this announcement is deemed by
the Group to constitute inside information as stipulated under the
Market Abuse Regulations (EU) No. 596/2014 ('MAR'). Upon the
publication of this announcement via a Regulatory Information
Service ('RIS'), this inside information is now considered to be in
the public domain.
For immediate release 27(th) February 2020
Haydale Graphene Industries plc
('Haydale', the 'Company', or the 'Group')
Interim Results
Haydale (AIM: HAYD), the global advanced materials group ,
announces its unaudited interim results for the six months ended 31
December 2019 (the 'Period' or 'H1 2020').
Financial Highlights
-- Group Revenues of GBP1.35 million for the Period, 17% down on H1 2019;
-- Adjusted administrative expenses fell by 17% with a saving of
GBP0.68 million on the prior year half year;
-- Adjusted operating loss for the Period reduced by 22% (H1
2020 GBP2.1 million vs H1 2019 GBP2.7 million);
-- Cash at Period end of GBP2.70 million (30 June 2019: GBP4.69 million); and
-- New share subscription of GBP0.45 million at approximately a
29% premium to closing mid-market price.
Operational Highlights
-- US blanks production now at commercial levels after some earlier teething issues;
-- Decision taken to close loss-making Taiwan manufacturing
facility and transfer production to both our UK and Thailand
operations, expected to result in a reduction in turnover but
improved EBITDA for H2 2020;
-- Rightsizing of the Group's cost base has continued, with a
reduction of GBP0.68 million adjusted administrative expenses in
the Period.
Commenting on the interim results, Keith Broadbent, Chief
Executive Officer of Haydale, said:
Whilst both internal and external factors have adversely
impacted our short-term revenues, the Directors remain committed to
delivering on the commercial potential of our stable of world
leading technologies. We are making significant progress, in
collaboration with a number of international partners, towards
converting state of art science into everyday applications that
will positively impact our customers' businesses. Our proprietary
technology and our exceptional ability to functionalise nano
materials continues to give us confidence in the longer-term
prospects of the Group.
For further information:
Haydale Graphene Industries plc
Keith Broadbent, CEO Tel: +44 (0) 1269 842 946
Gemma Smith, Head of Marketing www.haydale.com
Arden Partners plc (Nominated Adviser
& Broker)
Ruari McGirr / Paul Shackleton / Tel: +44 (0) 20 7614 5900
Ben Cryer
Notes to Editors
Haydale is a global technologies group and service provider that
facilitates the integration of graphene and other nanomaterials
into the next generation of industrial materials and commercial
technologies. With expertise in graphene, silicon carbide and other
nanomaterials, Haydale is able to deliver improvements in
electrical, thermal and mechanical properties, as well as
toughness. Haydale has been granted patents for its technologies in
Europe, USA, Australia, Japan and China and operates from five
sites in the UK, USA and the Far East. For more information please
visit: www.haydale.com or Twitter: @haydalegraphene
Caution regarding forward looking statements
Certain statements in this announcement, are, or may be deemed
to be, forward looking statements. Forward looking statements are
identi ed by their use of terms and phrases such as "believe",
"could", "should" "envisage", "estimate", "intend", "may", "plan",
"potentially", "will" or the negative of those, variations or
comparable expressions, including references to assumptions. These
forward looking statements are not based on historical facts but
rather on the Directors' current expectations and assumptions
regarding the Company's future growth, results of operations,
performance, future capital and other expenditures (including the
amount, nature and sources of funding thereof), competitive
advantages, business prospects and opportunities. Such forward
looking statements re ect the Directors' current beliefs and
assumptions and are based on information currently available to the
Directors.
A number of factors could cause actual results to differ
materially from the results discussed in the forward looking
statements including risks associated with vulnerability to general
economic and business conditions, competition, environmental and
other regulatory changes, actions by governmental authorities, the
availability of capital markets, reliance on key personnel,
uninsured and underinsured losses and other factors, many of which
are beyond the control of the Company. Although any forward looking
statements contained in this announcement are based upon what the
Directors believe to be reasonable assumptions, the Company cannot
assure investors that actual results will be consistent with such
forward looking statements. Accordingly, readers are cautioned not
to place undue reliance on forward looking statements. Subject to
any continuing obligations under applicable law or any relevant AIM
Rule requirements, in providing this information the Company does
not undertake any obligation to publicly update or revise any of
the forward looking statements or to advise of any change in
events, conditions or circumstances on which any such statement is
based.
Chief Executive's Report
Overview
The Group experienced a softer start to the financial year than
anticipated and, in particular, sales of silicon carbide ("SiC")
whiskers and blends in H1 2020 were disappointing and reflected
wider issues experienced within the US aerospace and petrochemical
sectors. Sales within the Group's other regions were below
expectations but showed improvement year on year which we expect to
continue, albeit at a more gradual pace than originally
forecast.
As previously announced the Board has decided to close the
Group's loss-making manufacturing facility in Taiwan and move
capacity to its APAC Knowledge Centre in Bangkok and its
manufacturing facility in Ammanford. This shift will be completed
in H2 2020.
Notwithstanding that revenues for the Period were down on the
prior year period (H1 2020 GBP1.35 million vs H1 2019 GBP1.64
million) the Group's adjusted operating loss showed a 24% reduction
(H1 2020 GBP2.1 million vs H1 2019 GBP2.7 million). The anticipated
costs savings of GBP0.68 million have been realised in the H1 2020
results and, although further cost reduction measures are being
implemented, the Directors do not envisage that these will have a
similar impact as those achieved to date.
The strategic focus on SiC and the related cutting tools
("blanks"), functionalised inks and graphene composites remains at
the heart of the operational purpose and, within this plan, the
Directors will continue to exercise cost control as a necessity and
cost reduction where it does not adversely impact operational
priorities.
The Board welcomed Mark Chapman as the Group's Chief Financial
Officer on 22 November 2019.
Operations
The Board took the decision to close the loss-making Taiwan
manufacturing facility and move production to the Ammanford site
and the Thailand Knowledge centre. Notwithstanding the previous
investment in the Taiwan operation, the Directors could see no
realistic prospect of that business unit moving into profitability
in the medium term. As noted in the Group's 2019 Annual Report and
Accounts, the unit was 'receiving regular repeat orders, albeit
still in relatively small quantities.' During H1 2020 we saw no
expansion of these orders and, after a reassessment of the
prognosis for this operation, the decision was taken to close the
facility. The Directors expect the closure and reallocation of
resources to be completed by the end of June 2020.
Our Asia Pacific ("APAC") hub in Thailand continued to make good
progress in the Period towards commercialising Haydale's
proprietary technology in conjunction with a number of key national
business champions. The APAC hub has also acted as a springboard
into other APAC countries including China and the Group is
currently considering a number of opportunities within that region
that will allow for wider exploitation of its PATit (non-visualised
graphene security code) ink technology. The knowledge centre in
Thailand is supported in realising these prospects by our sales
engineer in Seoul. Although revenue growth there has been more
modest than anticipated, the Directors expect the position to
improve in H2 2020. Notwithstanding this, the Group continues to
monitor its prospects in the APAC region as part of its on-going
strategic review.
Revenue at our US SiC manufacturing facility has lagged our
initial forecasts as the business was subject to the issues that
have been widely reported in the US aerospace and petrochemical
sectors. Sales of the Group's SiC whisker and blends showed a
like-for-like fall in H1 2020 of 43% which, given the historic
predictability of this revenue stream, has been frustrating. Whilst
we anticipate that inventory levels will not fully rebound in H2
2020, we do foresee a stronger sales pattern emerging as customers
have adjusted their stock holdings and are now resuming a steadier
purchasing pattern. The Group has sought to counteract this subdued
activity by looking for alternative uses for its SiC and has
recently completed the successful trial of a new barrier coating
with a major utility business.
To compound this wider industry slowdown, the US facility also
encountered teething problems with its blanks line as it scaled up
to commercial production levels. We are pleased to report that
these issues have now been resolved and the unit is now shipping to
those customers that pre-approved the blanks in 2019. Subsequent to
the year-end, strong traction with new customers in the US and APAC
region has given the Directors the confidence to move the US
facility to a double shift pattern from early February 2020. The
growth in the blanks business should allow the Group to make a
solid return on its investment and, despite the short delays, the
forecast payback period is expected to be less than our initial
projection. We anticipate that the blanks production will
contribute to a higher utilisation of the wider manufacturing
capacity at the US facility and, as we move up the value chain,
will lead to higher value sales than the historic SiC
operation.
The UK division has made meaningful progress towards
commercialising its proprietary technology and to delivering on
some of the previously announced collaborations. It is rewarding to
see the BAC Mono car moving to the commercial production stages
with the use of graphene enhanced composites for a number of the
body panels. In line with the refocus towards revenue generation,
the Group has formalised the technical specifications of six new
products which it is confident can deliver the promoted material
enhancement and can be manufactured to an industrial scale. This
important step forward has attracted interest from some significant
global businesses in the aerospace and automotive sectors who can
now readily understand the level of electrical, thermal and
mechanical enhancements achievable and the potential benefit that
our functionalised nano materials could offer them.
Excluding grant income, the UK division has shown an increase in
like-for-like sales but, due to the longer than anticipated lead
times, it has fallen short of its original forecast for H1 2020. We
expect the business to improve in H2 2020 but, unless some of the
significant pipeline opportunities crystallise ahead of schedule,
we do not expect the business to recoup the shortfall seen to date
by the end of the current financial year.
Grant income remains on target, although we continue to take a
more critical approach to accepting new proposals and expect this
revenue stream to decline marginally as commercial projects
increasingly take priority. However, to the extent that grant
funded research aligns with our commitment to the continuous
improvement in the capabilities of our plasma reactors and related
processes, then these projects remain an important element of our
business.
As previously announced, our global sales team was further
strengthened in H1 2020 with the addition of UK sales expertise
both in the inks and composites sectors. The enlarged team is
already delivering positive results with a strong pipeline of
potentially profitable opportunities being actively pursued. It has
been rewarding to see that closer collaboration fostered between
the regional teams has, amongst other accomplishments, led to the
successful phase one trial of a US coatings solution in the EMEA
region. As we further capitalise on our world leading nanomaterial
expertise and technological know-how, we foresee the need to
further invest in our global sales team.
Unaudited Financial Results
The Group's recognised commercial income in the Period of
GBP1.35 million (H1 2019 GBP1.64 million). Of this, GBP0.94 million
(H1 2019: GBP1.28 million) derived from the US with the sales of
SiC nanomaterials and blanks with the balance being sales of
functionalised nanomaterials for speciality inks and composites
from the UK and APAC region. The Company did not sell any plasma
reactors in the Period.
During the past year, management has concentrated on reducing
costs across all areas of the Group. This focus has borne fruit
with total administrative expenses being reduced by GBP0.9 million,
equivalent to 19% (H1 2020 GBP3.8 million vs H1 2019 GBP4.7
million) and adjusted administrative expenses (excluding share
based payments, restructuring costs and depreciation/amortisation)
by GBP0.7 million or 17% (H1 2020 GBP3.8 million vs H1 2019 GBP4.7
million). This has been achieved notwithstanding the investment in
further sales resources as Haydale transitions from an R&D
focused operation to one delivering a commercially viable product
range.
The Group's adjusted operating loss for H1 2020 reduced by 22%
(H1 2020 GBP2.1 million vs H1 2019 GBP2.7 million) and the Loss
before taxation was GBP2.7 million compared to GBP3.5 million in H1
2019. Following completion of the capital investment in the US
blanks production in FY 2019, capital expenditure in H1 2020 shrunk
to GBP0.2 million (H1 2019: GBP1.0 million) and capex is forecast
to remain similarly restrained through H2 2020.
The Group's net assets at 31 December 2019 were GBP9.06 million
(31 December 2018: GBP9.26 million). The Group's borrowings reduced
by GBP0.54 million during the Period to GBP0.70 million at the
Period end (30 June 2019: GBP1.25 million). Cash at the Period end
was GBP2.7 million (30 June 2019: GBP4.7 million), including the
GBP0.45 million of new equity funds received in November 2019. The
reduction in cash balances during the Period of GBP2.0 million (H1
2019: GBP4.1 million) showed a significant reduction in cash burn
compared with the prior period notwithstanding the reduced levels
of capital investment. The reduction was broadly made up of GBP2.1
million of operational losses, GBP0.4 million of investment in
working capital, GBP0.2 million of capital expenditure and the
balance being repayments of borrowings offset with cash inflows of
GBP0.44 million from R&D tax credits and GBP0.45 million from
the equity subscriptions. We are expecting operating losses to
reduce and the investment in inventory, principally in the US, to
unwind in H2 2020 thus reducing the rate of cash burn.
The Company raised GBP0.45 million via the issue of 22,500,000
new ordinary shares in November 2019 at a price of GBP0.02 each
(the "Subscription"), representing a premium of approximately 29%
to the closing mid-market price of the Company's shares immediately
before the Subscription. As at 31 December 2019, and at the date of
this announcement, the Company had 340,223,850 ordinary shares in
issue.
Board changes
In November 2019, Mark Chapman was appointed to the role of the
Group's CFO, replacing Laura Redman-Thomas who left the Company. On
behalf of the Board I would like to thank Laura for her service to
the Company.
Outlook
The Directors remain committed to delivering the strategic plan
that was set out in early 2019. The commercial sales of
functionalised inks and graphene enhanced composites remain a
priority alongside capturing the economic upside of our investment
in the more mature US SiC and blanks operation. We look ahead to H2
2020 showing a more robust turnaround in sales and a reduced
operating loss compared to H2 2019 and on a full year-on-year
basis. Cost control remains a focus, but the Directors recognise
that investment in further resource will be required to drive sales
of the new product lines. Therefore, the level of overall cost
reduction will reduce within the wider rebalancing towards a
structure geared to achieving commercial success.
Keith Broadbent
Chief Executive Officer
26(th) February 2020
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (UNAUDITED)
For the six months ended 31 December 2019
Note Unaudited Unaudited Audited
Six months Six months Year
ended ended ended
31 Dec 2019 31 Dec 2018 30 Jun 2019
GBP'000 GBP'000 GBP'000
REVENUE 1,347 1,635 3,467
Cost of sales (509) (758) (1,567)
-------------- -------------- --------------
Gross Profit 838 877 1,900
Other operating income 320 377 785
Adjusted Administrative
expenses (3,268) (3,951) (6,865)
-------------- --------------
Adjusted operating loss (2,110) (2,697) (4,180)
Adjusting administrative
items:
Share based payments income/(expenses) 142 (147) (200)
Restructuring costs (123) - (350)
Depreciation and amortisation (539) (591) (1,118)
-------------- -------------- --------------
(520) (738) (1,668)
-------------- -------------- --------------
Total trading administrative
expenses (3,788) (4,689) (8,533)
-------------- -------------- --------------
LOSS FROM TRADING (2,630) (3,435) (5,848)
Impairment - - (1,784)
-------------- -------------- --------------
Total administrative expenses (3,788) (4,689) (10,317)
-------------- -------------- --------------
LOSS FROM OPERATIONS (2,630) (3,435) (7,632)
Finance costs (94) (36) (123)
-------------- -------------- --------------
LOSS BEFORE TAXATION (2,724) (3,471) (7,755)
Taxation 159 143 570
-------------- -------------- --------------
LOSS FOR THE YEAR FROM CONTINUING
OPERATIONS (2,565) (3,328) (7,185)
Other comprehensive income:
Items that may be reclassified
to profit or loss:
Exchange differences on
translation of foreign operations (99) 5 60
Remeasurements of defined
benefit pension scheme 174 (109) 2
-------------- -------------- --------------
TOTAL COMPREHENSIVE LOSS
FOR THE YEAR FROM CONTINUING
OPERATIONS (2,490) (3,432) (7,123)
-------------- -------------- --------------
Loss per share attributable
to owners of the Parent
Basic (GBP) and Diluted
(GBP) 2 (0.01) (0.13) (0.06)
-------------- -------------- --------------
CONSOLIDATED STATEMENT OF FINANCIAL POSITION (UNAUDITED)
As at 31 December 2019
Unaudited Unaudited Audited
31 Dec 2019 31 Dec 2018 30 Jun 2019
GBP'000 GBP'000 GBP'000
ASSETS
Non-current assets
Goodwill 1,454 2,088 1,453
Intangible assets 1,078 1,950 1,024
Property, plant and equipment 4,815 5,751 5,556
Deferred tax asset - 680 -
7,347 10,469 8,033
Current assets
Inventories 1,618 1,255 1,182
Trade receivables 512 861 637
Other receivables 352 314 472
Corporation tax 149 547 836
Cash and bank balances 2,700 961 4,688
5,331 3,938 7,815
TOTAL ASSETS 12,678 14,407 15,848
LIABILITIES
Non-current liabilities
Bank loans 234 526 388
Deferred tax - 820 -
Pension obligation 894 1,173 1,085
1,128 2,519 1,473
Current liabilities
Bank loans 470 270 859
Trade and other payables 1,852 2,197 2,056
Deferred income 173 165 209
2,495 2,632 3,124
TOTAL LIABILITIES 3,623 5,151 4,597
TOTAL NET ASSETS 9,055 9,256 11,251
EQUITY
Capital and reserves attributable to
equity holders of the parent
Share capital 6,804 547 6,354
Share premium account 27,764 27,539 27,764
Share-based payment reserve 686 1,445 828
Retained (deficits) (26,000) (20,120) (23,595)
Foreign exchange reserve (199) (155) (100)
TOTAL EQUITY 9,055 9,256 11,251
CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED)
For the six months ended 31 December 2019
Unaudited Unaudited Audited
Six months Six months Year
ended ended ended
31 Dec 31 Dec 30 Jun
2019 2018 2019
GBP'000 GBP'000 GBP'000
Cash flow from operating activities
Loss before taxation (2,724) (3,471) (7,755)
Adjustments for:-
Amortisation of intangible assets 68 180 2,007
Depreciation of property, plant
and equipment 471 411 895
Share-based payment (income)/charge (142) 147 200
Loss/(Profit) on disposal of
property, plant and equipment 123 - 16
Pension plan contributions - (120) (118)
Finance costs 94 36 123
Pension - net interest expense 22 19 42
Operating cash flow before working
capital changes (2,088) (2,798) (4,590)
(Increase) in inventories (435) (233) (401)
Decrease / (increase) in trade
and other receivables 245 (108) 200
(Decrease)/increase in payables
and deferred income (240) 112 13
Cash used in operations (2,518) (3,027) (4,778)
------------ ------------ ---------
Income tax received 846 76 76
Net cash used in operating activities (1,672) (2,951) (4,702)
------------ ------------ ---------
Cash flow used in investing
activities
Purchase of property, plant
and equipment (28) (964) (1,205)
Capitalisation of intangible
assets (121) - (267)
Net cash used in investing activities (149) (964) (1,472)
------------ ------------ ---------
Cash flow used in financing
activities
Finance costs (94) (36) (123)
Proceeds from issue of share
capital (net of share issue
costs) 436 - 5,634
New bank loans raised - - 750
Repayments of borrowings (545) (149) (500)
Net cash flow from financing
activities (203) (185) 5,761
------------ ------------ ---------
Effects of exchange rate changes 36 (31) 9
Net (decrease) in cash and cash
equivalents (1,988) (4,131) (404)
Cash and cash equivalents at
beginning of the financial period 4,688 5,092 5,092
Cash and cash equivalents at
end of the financial period 2,700 961 4,688
============ ============ =========
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (UNAUDITED)
Share-based Foreign
Share Share payment exchange Retained
Capital premium reserve reserve profits Total
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
At 1 July 2018 547 27,539 1,298 (160) (16,683) 12,541
Total comprehensive
loss for the period - - - 5 (3,437) (3,432)
Recognition of
share-based
payments - - 147 - - 147
At 31 December 2018 547 27,539 1,445 (155) (20,120) 9,256
Total comprehensive
loss for the period - - - 55 (3,746) (3,691)
Recognition of
share-based
payments - - 53 - - 53
Share based payment
charges - lapsed options - - (670) - 670 -
Issue of ordinary share
capital 5,807 225 - - - 6,032
Transaction costs in
respect of share issues - - - - (399) (399)
At 30 June 2019 6,354 27,764 828 (100) (23,595) 11,251
Total comprehensive
loss for the period - - - (99) (2,391) (2,490)
Recognition of
share-based
payments - - (142) - - (142)
Issue of ordinary share
capital 450 - - - - 450
Transaction costs in
respect of share issues - - - - (14) (14)
At 31 December 2019 6,804 27,764 686 (199) (26,000) 9,055
========== ================ ============= =========== ========== =========
Equity share capital and share premium
The balance classified as share capital and share premium
includes the total net proceeds on issue of the Company's equity
share capital, comprising GBP0.02 ordinary shares. The share
premium account can only be used for bonus issues, to provide for
the premium payable on redemption of debentures or to write off
preliminary expenses, or expenses of, or commissions paid on, or
discounts allowed on, any issues of shares or debentures of the
company.
Share premium account
The share premium account represents the amount received on the
issue of ordinary shares in excess of their nominal value and is
non-distributable.
Share-based payment reserve
The share-based payment reserve comprises the cumulative expense
representing the extent to which the vesting period of share
options has expired and management's best estimate of the
achievement or otherwise of non-market conditions and the number of
equity instruments that will ultimately vest.
Retained profits
The retained profits reserve comprises the cumulative effect of
all other net gains, losses and transactions with owners (e.g.
dividends) not recognised elsewhere.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For the six months ended 31 December 2019
1. Accounting policies
Basis of preparation
The interim financial statements, which are unaudited, have been
prepared on the basis of the accounting policies expected to apply
for the financial year to 30 June 2020 and in accordance with
recognition and measurement principles of International Financial
Reporting Standards (IFRSs) as endorsed by the European Union. The
accounting policies applied in the preparation of these interim
financial statements are consistent with those used in the
financial statements for the year ended 30 June 2019.
The interim financial statements do not include all of the
information required for full annual financial statements and do
not comply with all of the disclosures in IAS34 'Interim Financial
Reporting'. Accordingly, while the interim financial statements
have been prepared in accordance with IFRS they cannot be construed
as being in full compliance with IFRS.
The financial information for the year ended 30 June 2019 does
not constitute the full statutory accounts for that period. The
Annual Report and Accounts for 30 June 2019 have been filed with
the Registrar of Companies. The Independent Auditors' Report on the
Annual Report and Accounts for 2019 was unqualified and did not
include references to any matters which the auditors drew attention
to by way of emphasis without qualifying their report and did not
contain statements under Section 498(2) or 498(3) of the Companies
Act 2006.
Going concern
The consolidated financial statements are prepared on a going
concern basis which the Directors believe continues to be
appropriate. The Group meets its day-to-day working capital
requirements through existing cash resources which, at 31 December
2019 amounted to GBP2.7 million and included cash drawn from the
working capital facility held by the Group's US subsidiary, which,
as at 31 December 2019, stood at GBP0.68 million. The working
capital facility is secured against the US inventory and debtor
book, and is included in trade and other payables on the Statement
of Financial Position at the Period end. The Directors have
prepared cash flow projections for the period ending no less than
12 months from the date of their approval of these financial
statements. On the basis of those projections, the Directors
believe that the Group will be able to continue to trade for the
foreseeable future.
2. Loss per share
The calculations of loss per share are based on the following
losses and number of shares:
Unaudited Unaudited Audited
Six months Six months Year
ended ended ended
31 Dec 2019 31 Dec 2018 30 Jun 2019
GBP'000 GBP'000 GBP'000
Loss after tax attributable
to owners of the Haydale
Graphene Industries Group (2,565) (3,328) (7,185)
Weighted average number
of shares:
- Basic and Diluted 322,615,153 27,328,773 115,060,850
Loss per share:
- Basic (GBP) and Diluted
(GBP) (0.01) (0.13) (0.06)
The loss attributable to ordinary shareholders and weighted
average number of ordinary shares for the purpose of calculating
the diluted earnings per ordinary share are identical to those used
for basic earnings per share. This is because the exercise of share
options would have the effect of reducing the loss per ordinary
share and is therefore not dilutive under the terms of IAS 33.
3. Approval
The 31 December 2019 interim financial statements were approved
by a duly appointed and authorised committee of the Board of
Directors on 26(th) February 2020
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
IR VQLFLBLLBBBF
(END) Dow Jones Newswires
February 27, 2020 02:00 ET (07:00 GMT)
Haydale Graphene Industr... (LSE:HAYD)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Haydale Graphene Industr... (LSE:HAYD)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
